Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
Year: 2016
Type: article
Abstract: Malignancies represent the leading cause of death in patients infected with HIV.[1] Such individuals manifest increased incidence of both AIDS-defining cancers (e.g. Kaposi sarcoma and non-Hodgkin ...
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1000381934, G1266999854, G1347238333, G1545560008, G1548551769, G157993030, Stanford University NCTN- Network Lead Academic Site, G1814228702, ECOG-ACRIN Network Group Operations Center, G1938688226, G2002724969, G2117393317, G2406815399, G257334518, COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM, G2934225706, UCDCCC NCTN U10 Program, G3295642875, G332150848, G3484997517, City of Hope Southwest Oncology Group Clinical Trials, G4289044101, G4768276527, G4879059600, G5448779787, G5555226376, G5671623325, G6211207823, Cancer Research Consortium of West Michigan (CRCWM), G6710502012, G6844086745, G6880957883, G6970698343, Yale Cancer Center NCTN, G7222907299, Johns Hopkins University NCTN Lead Academic Site Program, G7926913928, SOUTHWEST ONCOLOGY GROUP, Alliance for Clinical Trials in Oncology Operations Center, G8740717309, G8777682367, Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming, National Clinical Trials Network Research at the University of Wisconsin, G8898045420, G9000058070, Cancer Center Support Grant, G929330420, G93539815
OpenAlex ID: W2467220940
